logo

Since transitioning to a holding company structure, Dong-A Socio Group has grown by strengthening the expertise of each affiliate. In particular, Dong-A Pharmaceutical has expanded from a Bacchus-centered business structure into the broader consumer healthcare sector and established itself as a core operating company of the Group.

The internal and external environment of the healthcare industry is changing faster than ever. The domestic market is shrinking due to low birth rates and an aging population, while external challenges such as high oil prices and high interest rates are making the business environment even more difficult.

To respond proactively to these market conditions, we have decided to transition into a 'business holding company' structure through a merger with Dong-A Pharmaceutical.

This merger and the change of corporate name are not merely changes in organization or name, but steps to grow further as an operating holding company. Even after the merger, we promise to continue inheriting the products, services, customer trust, and identity that Dong-A Pharmaceutical has built over many years, and to repay your support through the sustainable growth of the 'new Dong-A Pharmaceutical.'

First, Dong-A Pharmaceutical has steadily built trust in the consumer healthcare market and delivered stable results. Through this merger, the 'new Dong-A Pharmaceutical' will internalize this brand competitiveness and cash-generating capability, thereby solidifying the strength and capacity needed for future growth.

Second, this merger will enable faster decision-making and more efficient group operations. It will also fundamentally resolve the issue of overlapping listings among subsidiaries, allowing the corporate value of the 'new Dong-A Pharmaceutical' to be properly recognized.

Finally, this merger was made possible by the continued support of customers, shareholders, and employees who have trusted and stood with Dong-A Pharmaceutical for a long time. Based on the trust built through our long history, the 'new Dong-A Pharmaceutical' will continue to move forward as a company that is not afraid of change and challenge. We ask for your continued interest and support, and wish you lasting health and happiness.

Thank you.